Akademska digitalna zbirka SLovenije - logo

Rezultati iskanja

Osnovno iskanje    Ukazno iskanje   

Trenutno NISTE avtorizirani za dostop do e-virov konzorcija SI. Za polni dostop se PRIJAVITE.

1 2 3 4 5
zadetkov: 252
1.
  • Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?
    Leboulleux, Sophie; Tuttle, R Michael; Pacini, Furio ... The lancet. Diabetes & endocrinology, 11/2016, Letnik: 4, Številka: 11
    Journal Article
    Recenzirano
    Odprti dostop

    The incidence of differentiated thyroid cancer is increasing greatly in high-income countries. Roughly 50% of this increase is attributable to the identification of intrathyroidal papillary thyroid ...
Celotno besedilo
Dostopno za: NUK, OILJ, UL

PDF
2.
  • Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma
    Wells, Jr, Samuel A; Asa, Sylvia L; Dralle, Henning ... Thyroid (New York, N.Y.) 25, Številka: 6
    Journal Article
    Recenzirano
    Odprti dostop

    The American Thyroid Association appointed a Task Force of experts to revise the original Medullary Thyroid Carcinoma: Management Guidelines of the American Thyroid Association. The Task Force ...
Celotno besedilo

PDF
3.
Celotno besedilo
Dostopno za: NUK, OILJ, UL
4.
  • Sorafenib in radioactive io... Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
    Brose, Marcia S, Dr; Nutting, Christopher M, Prof; Jarzab, Barbara, Prof ... The Lancet, 07/2014, Letnik: 384, Številka: 9940
    Journal Article
    Recenzirano
    Odprti dostop

    Summary Background Patients with radioactive iodine (131 I)-refractory locally advanced or metastatic differentiated thyroid cancer have a poor prognosis because of the absence of effective treatment ...
Celotno besedilo
Dostopno za: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK

PDF
5.
  • DIO2 Thr92Ala Reduces Deiod... DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients
    Castagna, Maria Grazia; Dentice, Monica; Cantara, Silvia ... The journal of clinical endocrinology and metabolism, 05/2017, Letnik: 102, Številka: 5
    Journal Article
    Recenzirano
    Odprti dostop

    Abstract Context: A substantial proportion of athyreotic levothyroxine (LT4)-treated patients experience hypothyroid-like symptoms. During LT4 replacement, levels of the active hormone ...
Celotno besedilo
Dostopno za: NUK, UL, UM, UPUK

PDF
6.
  • A Phase II Trial of the Mul... A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer
    Schlumberger, Martin; Jarzab, Barbara; Cabanillas, Maria E ... Clinical cancer research, 2016-Jan-01, 2016-01-01, 20160101, Letnik: 22, Številka: 1
    Journal Article
    Recenzirano
    Odprti dostop

    Positive results of phase I studies evaluating lenvatinib in solid tumors, including thyroid cancer, prompted a phase II trial in advanced medullary thyroid carcinoma (MTC). Fifty-nine patients with ...
Celotno besedilo
Dostopno za: CMK, NUK, UL, UM, UPUK

PDF
7.
  • Thyroid microcarcinoma Thyroid microcarcinoma
    Pacini, Furio, MD Best Practice & Research Clinical Endocrinology & Metabolism, 08/2012, Letnik: 26, Številka: 4
    Journal Article
    Recenzirano

    Nowadays the most commonly occurring differentiated thyroid cancer in many countries is a microcarcinoma in patients older than 45 years, incidentally found during neck ultrasound. In view of their ...
Celotno besedilo
Dostopno za: GEOZS, IJS, IMTLJ, KILJ, KISLJ, NUK, OILJ, PNG, SAZU, SBCE, SBJE, UL, UM, UPCLJ, UPUK
8.
  • Delayed risk stratification... Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients
    Castagna, Maria Grazia; Maino, Fabio; Cipri, Claudia ... European journal of endocrinology, 09/2011, Letnik: 165, Številka: 3
    Journal Article
    Recenzirano
    Odprti dostop

    IntroductionAfter initial treatment, differentiated thyroid cancer (DTC) patients are stratified as low and high risk based on clinical/pathological features. Recently, a risk stratification based on ...
Celotno besedilo
Dostopno za: NUK, UL, UM, UPUK

PDF
9.
  • 2022 ETA Consensus Statemen... 2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
    Pacini, Furio; Fuhrer, Dagmar; Elisei, Rossella ... European thyroid journal, 2022, Letnik: 11, Številka: 1
    Journal Article
    Recenzirano
    Odprti dostop

    Modern use of post-operative radioactive iodine (RAI) treatment for differentiated thyroid cancer (DTC) should be implemented in line with patients’ risk stratification. Although beneficial effects ...
Celotno besedilo
Dostopno za: NUK, UL, UM, UPUK

PDF
10.
  • Management of advanced medullary thyroid cancer
    Hadoux, Julien; Pacini, Furio; Tuttle, R Michael ... The lancet. Diabetes & endocrinology, 01/2016, Letnik: 4, Številka: 1
    Journal Article
    Recenzirano

    Medullary thyroid cancer arises from calcitonin-producing C-cells and accounts for 3-5% of all thyroid cancers. The discovery of a locally advanced medullary thyroid cancer that is not amenable to ...
Celotno besedilo
Dostopno za: NUK, OILJ, UL
1 2 3 4 5
zadetkov: 252

Nalaganje filtrov